DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag.

about

DNA demethylation marks in chronic lymphocytic leukemia: it is time to let the cat out of the bag.

Item

http://www.wikidata.org/entity/Q47705922

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

DNA demethylation marks in chr ...... to let the cat out of the bag.

@en

DNA demethylation marks in chr ...... to let the cat out of the bag.

@nl

type

Item

label

DNA demethylation marks in chr ...... to let the cat out of the bag.

@en

DNA demethylation marks in chr ...... to let the cat out of the bag.

@nl

prefLabel

DNA demethylation marks in chr ...... to let the cat out of the bag.

@en

DNA demethylation marks in chr ...... to let the cat out of the bag.

@nl

P1476

DNA demethylation marks in chr ...... to let the cat out of the bag.

@en

P2093

Adrian Tempescul

http://www.w3.org/2001/XMLSchema#string

Christelle Le Dantec

http://www.w3.org/2001/XMLSchema#string

Christian Berthou

http://www.w3.org/2001/XMLSchema#string

Cristina Bagacean

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue distribution of 5-hydroxymethylcytosine and search for active demethylation intermediates

Structural insight into substrate preference for TET-mediated oxidation

Ten-Eleven-Translocation 2 (TET2) negatively regulates homeostasis and differentiation of hematopoietic stem cells in mice

Towards precision medicine.

B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes.

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.

Acquired initiating mutations in early hematopoietic cells of CLL patients.

Alteration in 5-hydroxymethylcytosine-mediated epigenetic regulation leads to Purkinje cell vulnerability in ATM deficiency.

5-Hydroxymethylcytosine is a predominantly stable DNA modification.

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

P304

FSO265

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.4155/FSOA-2017-0120

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mihnea Zdrenghea

Yves Renaudineau

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29379639

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

P932

5778384

http://www.w3.org/2001/XMLSchema#string